0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global lysosomal alpha glucosidase market research report 2019.Your search for "" gave back 1533066 results.
The global Oral Hypoglycemic Agents and Insulin Analogues market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) Development by Therapy Areas and Indications, Stages...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
The global Oral Antidiabetic Drugs market size was valued at US$ 1803.9 million in 2023. With growing demand in downstream market, the Oral...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,000.00
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Lysosomal disease treatment is a way to alleviate Lysosomal storage disease. The global Lysosomal Disease Treatment market was valued at US$ million...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Lysosomal Acid Lipase Deficiency (LALD) Treatment market was valued at US$ 476.5 million in 2023 and is anticipated to reach US$ 860.9...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 Summary Alpha N-...
Catalog:
Global Markets Direct
December 2021
Price: USD 3,500.00
Alpha N-Acetylglucosaminidase - Pipeline Review, H1 2020 Summary Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1...
Catalog:
Global Markets Direct
June 2020
Price: USD 3,500.00
Pompe Disease - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pompe...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) Drugs in Development by Stages, Target, MoA, RoA, Molecule...
Catalog:
Global Markets Direct
December 2022
Price: USD 3,500.00
